comparemela.com

Latest Breaking News On - Antibiotice iasi - Page 8 : comparemela.com

Antibiotice Iasi s Net Profit More Than Doubles YoY To RON80 7M In 2023

Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) ended 2023 with net profit of RON80.7 million, up 109.5% from 2022, and a turnover of RON600.8 million, up 7.2% on the year, in line with calculations by Ziarul Financiar (ZF) daily based on data from the company's annual preliminary financial report published at the Bucharest Stock Exchange.

Antibiotice Iasi s Net Profit More Than Doubles YoY To RON80 7M In 2023

Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) ended 2023 with net profit of RON80.7 million, up 109.5% from 2022, and a turnover of RON600.8 million, up 7.2% on the year, in line with calculations by Ziarul Financiar (ZF) daily based on data from the company's annual preliminary financial report published at the Bucharest Stock Exchange.

Antibiotice Iasi Launches New Vet Product Range

Antibiotice Iasi, the largest Romanian-held pharma producer, is launching eight veterinary products in the range of nutritional supplements, complementing the company’s veterinary prescription portfolio.

Antibiotice Iasi posts record export sales in 2019, highest growth rate in the last five years

Antibiotice Iasi posts record export sales in 2019, highest growth rate in the last five years
thediplomat.ro - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thediplomat.ro Daily Mail and Mail on Sunday newspapers.

Romania: Assets Of Top Ten Asset Management Firms In Romania Up 17% In ( )

Romania: Assets Of Top Ten Asset Management Firms In Romania Up 17% In ( )
romaniapress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from romaniapress.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.